documents: FDA-1976-N-0027-0122
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1976-N-0027-0122 | FDA | FDA-1976-N-0027 | Background Material (04NFMA3) - mo from Director, Division of OTC Drug Products, CDER to Robert J. Wolters, Ph.D., Chemist, Division of Cario-Renal Drug Products | Supporting & Related Material | BKG-Background Material | 2008-10-14T04:00:00Z | 2008 | 10 | 2015-11-10T16:32:22Z | 0 | 0 | 090000648051b68f |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref